Letter: proton pump inhibitors use and risk of hepatocellular carcinoma: A meta-analysis of observational studies

被引:5
作者
Zhao, Jian [1 ]
Hua, Li [1 ]
Li, Na [1 ]
An, Ran [1 ]
Liang, Chun [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Cardiol & Nursing, Shanghai, Peoples R China
关键词
D O I
10.1111/apt.14962
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Linked ContentThis article is linked Shao et al paper. To view this article visit .
引用
收藏
页码:886 / 888
页数:3
相关论文
共 7 条
[1]   Pantoprazole Inhibited the Carcinogenesis and Growth of Hepatocellular Carcinoma [J].
Jin, Hai ;
Liu, Jilong ;
Wen, Guorong ;
Xu, Jingyu ;
Weng, Han ;
Liu, Xuemei ;
Xie, Rui ;
Tuo, Biguang .
GASTROENTEROLOGY, 2016, 150 (04) :S1041-S1041
[2]   Proton pump inhibitors and risk of hepatocellular carcinoma: a population-based study [J].
Kao, W. -Y. ;
Su, C. -W. ;
Tan, E. C. -H. ;
Lee, P. -C. ;
Huang, Y. -H. ;
Chang, C. -C. ;
Hou, M. -C. ;
Lin, H. -C. ;
Wu, J. -C. .
JOURNAL OF HEPATOLOGY, 2018, 68 :S429-S429
[3]  
Lai SW, 2013, ACTA GASTRO-ENT BELG, V76, P348
[4]   Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES [J].
Li, D. K. ;
Yan, P. ;
Abou-Samra, A-B. ;
Chung, R. T. ;
Butt, A. A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) :246-258
[5]  
Li Y, 2015, WORLD CHINESE J DIGE, V23, P22
[6]   Association between proton pump inhibitors and the risk of hepatocellular carcinoma [J].
Shao, Y. -H. J. ;
Chan, T. -S. ;
Tsai, K. ;
Wu, S. -Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (04) :460-468
[7]   Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies [J].
Tran, K. T. ;
McMenamin, U. C. ;
Hicks, B. ;
Murchie, P. ;
Thrift, A. P. ;
Coleman, H. G. ;
Iversen, L. ;
Johnston, B. T. ;
Lee, A. J. ;
Cardwell, C. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) :55-64